CX Institutional’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4K Hold
100
﹤0.01% 1399
2026
Q1
$5K Sell
100
-149
-60% -$6.95K ﹤0.01% 1369
2025
Q4
$12K Buy
249
+218
+703% +$10.8K ﹤0.01% 1173
2025
Q3
$1K Hold
31
﹤0.01% 1363
2025
Q2
$1K Hold
31
﹤0.01% 1202
2025
Q1
$2K Buy
+31
New +$1.68K ﹤0.01% 1151
2022
Q3
Sell
-58
Closed -$3K 1031
2022
Q2
$3K Buy
+58
New +$3.08K ﹤0.01% 1073
2018
Q3
Sell
-136
Closed -$5K 354
2018
Q2
$5K Buy
+136
New +$5.35K ﹤0.01% 270

Other funds holding SNY

CX Institutional's SNY Position: Q2 2026 in Review

CX Institutional held its Sanofi (SNY) position steady in Q2 2026 at 100 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1399.

CX Institutional first reported a position in SNY in Q2 2018 and has held it in 8 quarters since. The position peaked at $12K in Q4 2025. 108 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • CX Institutional held 100 shares of Sanofi worth $4K as of Q2 2026.
  • CX Institutional left its Sanofi share count unchanged in Q2 2026.
  • Sanofi made up ﹤0.01% of CX Institutional's portfolio in Q2 2026, its #1399 holding.
  • CX Institutional first reported a position in Sanofi in Q2 2018 and has held it in 8 quarters since.
  • CX Institutional's Sanofi position peaked at $12K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.